Global challenge of antibiotic-resistant Treponema pallidum

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 2, 2010, Pages 583-589

  Stamm, Lola V ^a  

^a IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL PROTEIN; BENZATHINE PENICILLIN; CEPHALOSPORIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; PENICILLIN BINDING PROTEIN; PENICILLIN G; RIFAMPICIN; RNA 23S; RNA POLYMERASE BETA SUBUNIT; TETRACYCLINE;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIOSTASIS; BACTERIUM ISOLATION; BLOOD PLACENTA BARRIER; BRACHYSPIRA HYODYSENTERIAE; BRACHYSPIRA PILOSICOLI; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONGENITAL SYPHILIS; CONTINUOUS INFUSION; DESENSITIZATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION CONTROL; LONG TERM CARE; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; RECOMMENDED DRUG DOSE; RELAPSE; SHORT SURVEY; SINGLE DRUG DOSE; SYPHILIS; TREPONEMA PALLIDUM; VIRUS TRANSMISSION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MACROLIDES; MALE; PREGNANCY; SYPHILIS; TREPONEMA PALLIDUM;

EID: 75749123442     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01095-09     Document Type: Short Survey

References (87)

1. Alekshun, M., M. Kashlev, and I. Schwartz. 1997. Molecular cloning and characterization of Borrelia burgdorferi rpoB. Gene 186:227-235.
2. Bai, Z. G., K. H. Yang, Y. L. Liu, J. H. Tian, B. Ma, D. H. Mi, L. Jiang, J. Y. Tan, and Q. Y. Gai. 2008. Azithromycin vs. benzathine penicillin G for early syphilis: a meta-analysis of randomized clinical trials. Int. J. STD AIDS 19:217-221.
3. Brause, B. D., J. S. Borges, and R. B. Roberts. 1976. Relative efficacy of clindamycin, erythromycin, and penicillin in treatment of Treponema pallidum in skin syphilomas of rabbits. J. Infect. Dis. 134:93-96.
4. Centers for Disease Control and Prevention, K. A. Workowski, and S. M. Berman. 2006. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recommend. Rep. 55(RR-11):1-94.
5. Centers for Disease Control and Prevention. December 2008. Sexually transmitted diseases surveillance, 2007. U.S. Department Health and Human Services, Atlanta, GA.
6. Centers for Disease Control and Prevention. 2004. Brief report: azithromycin treatment failures in syphilis infections - San Francisco, California, 2002-2003. MMWR Morb. Wkly. Rep. 53:197-198.
7. Centurion-Lara, A., C. Castro, W. C. van Voorhis, and S. A. Lukehart. 1996. Two 16S-23S ribosomal DNA intergenic regions in different Treponema pallidum subspecies contain tRNA genes. FEMS Microbiol. Lett. 143:235-240.
8. Cha, J. Y., A. Ishiwata, and S. Mobashery. 2004. A novel beta-lactamase activity from a penicillin-binding protein of Treponema pallidum and why syphilis is still treatable with penicillin. J. Biol. Chem. 279:14917-14921.
9. Chen, J. L., D. B. Callahan, and P. R. Kerndt. 2002. Syphilis control among incarcerated men who have sex with men: public health response to an outbreak. Am. J. Public Health 92:1473-1474.
10. Chen, Z. Q., G. C. Zhang, X. D. Gong, C. Lin, X. Gao, G. J. Liang, X. L. Yue, X. S. Chen, and M. S. Cohen. 2007. Syphilis in China: results of a national surveillance programme. Lancet 369:132-138.
11. Cohen, M. S., G. E. Henderson, P. Aiello, and H. Zheng. 1996. Successful eradication of sexually transmitted diseases in the People's Republic of China: implications for the 21st century. J. Infect. Dis. 174(Suppl. 2):S223-S229.
12. Deka, R. K., M. Machius, M. V. Norgard, and D. R. Tomchick. 2002. Crystal structure of the 47-kDa lipoprotein of Treponema pallidum reveals a novel penicillin-binding protein. J. Biol. Chem. 277:41857-41864.
13. Dhawan, V. K., and H. Thadepalli. 1982. Clindamycin: a review of fifteen years of experience. Rev. Infect. Dis. 4:1133-1147.
14. Douglas, J. M., Jr. 2009. Penicillin treatment of syphilis-clearing away the shadow on the land. JAMA 301:769-771.
15. Fenton, L. J., and I. J. Light. 1976. Congenital syphilis after maternal treatment with erythromycin. Obstet. Gynecol. 47:492-494.
16. Fowler, V. G., Jr., G. L. Maxwell, S. A. Myers, C. R. Shea, C. N. Livengood III, V. G. Prieto, and C. B. Hicks. 2001. Failure of benzathine penicillin in a case of seronegative secondary syphilis in a patient with acquired immunodeficiency syndrome: case report and review of the literature. Arch. Dermatol. 137:1374-1376.
17. Fraser, C. M., S. J. Norris, G. M. Weinstock, O. White, G. G. Sutton, R. Dodson, M. Gwinn, E. K. Hickey, R. Clayton, K. A. Ketchum, E. Sodergren, J. M. Hardham, M. P. McLeod, S. Salzberg, J. Peterson, H. Khalak, D. Richardson, J. K. Howell, M. Chidambaram, T. Utterback, L. McDonald, P. Artiach, C. Bowman, M. D. Cotton, C. Fujii, S. Garland, B. Hatch, K. Horst, K. Roberts, M. Sandusky, J. Weidman, H. O. Smith, and J. C. Venter. 1998. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 281:375-388.
18. Ghanem, K. G., E. J. Erbelding, W. W. Cheng, and A. M. Rompalo. 2006. Doxycycline compared with benzathine penicillin for treatment of early syphilis. Clin. Infect. Dis. 42:e45-e49.
19. Greene, B. M., N. R. Miller, and T. E. Bynum. 1980. Failure of penicillin G benzathine in the treatment of neurosyphilis. Arch. Intern. Med. 140:1117-1118.
20. Harshan, V., and W. Jayskumar. 1982. Doxycycline in early syphilis: a long term follow up. Indian J. Dermatol. 27:119-124.
21. Holmes, K. K. 2005. Azithromycin versus penicillin G benzathine for early syphilis. N. Engl. J. Med. 353:1291-1293.
22. Holt, S. C., and J. L. Ebersole. 2006. The oral spirochetes: their ecology and role in the pathogenesis of periodontal disease, p. 323-356. In J. D. Radolf and S. A. Lukehart (ed.), Pathogenic Treponema molecular and cellular biology. Caister Academic Press, Norfolk, England.
23. Hook, E. W., III, D. H. Martin, J. Stephens, B. S. Smith, and K. Smith. 2002. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex. Transm. Dis. 29:486-490.
24. Hook, E. W., III, and R. W. Peeling. 2004. Syphilis control - a continuing challenge. N. Engl. J. Med. 351:122-124.
25. Hook, E. W., III, R. E. Roddy, and H. H. Handsfield. 1988. Ceftriaxone therapy for incubating and early syphilis. J. Infect. Dis. 158:881-884.
26. Hook, E. W., III, J. Stephens, and D. M. Ennis. 1999. Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis. Ann. Intern. Med. 131:434-437.
27. Huigen, E., and E. Stolz. 1974. Action of rifampicin on Treponema pallidum. Br. J. Vener. Dis. 50:465.
28. Karlsson, M., C. Fellstrom, M. U. Heldtander, K. E. Johansson, and A. Franklin. 1999. Genetic basis of macrolide and lincosamide resistance in Brachyspira (Serpulina) hyodysenteriae. FEMS Microbiol. Lett. 172:255-260.
29. Karlsson, M., C. Fellstrom, K. E. Johansson, and A. Franklin. 2004. Anti-microbial resistance in Brachyspira pilosicoli, with special reference to point mutations in 23S rRNA gene associated with macrolide and lincosamide resistance. Microb. Drug Resist. 10:204-208.
30. Katz, K. A., and J. D. Klausner. 2008. Azithromycin resistance in Treponema pallidum. Curr. Opin. Infect. Dis. 21:83-91.
31. Kiddugavu, M. G., N. Kiwanuka, M. J. Wawer, D. Serwadda, N. K. Sewankambo, F. Wabwire-Mangen, F. Makumbi, X. Li, S. J. Reynollds, T. C. Quinn, the Rakai Study Group, and R. H. Gray. 2005. Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. Sex. Transm. Dis. 32:1-6.
32. Kim, B. J., S. H. Lee, M. A. Lyu, S. J. Kim, G. H. Bai, S. J. Kim, G. T. Chae, E. C. Kim, C. Y. Cha, and Y. H. Kook. 1999. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J. Clin. Microbiol. 37:1714-1720.
33. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
34. Lee, S. H., B. J. Kim, J. H. Kim, K. H. Park, S. J. Kim, and Y. H. Kook. 2000. Differentiation of Borrelia burgdorferi sensu lato on the basis of RNA polymerase gene (rpoB) sequences. J. Clin. Microbiol. 38:2557-2562.
35. Lee, S. Y., Y. Ning, and J. C. Fenno. 2002. 23S rRNA point mutation associated with erythromycin resistance in Treponema denticola. FEMS Microbiol. Lett. 207:39-42.
36. Leschine, S. B., and E. Canale-Parola. 1986. Rifampin resistant RNA polymerase in spirochetes. FEMS Microbiol. Lett. 35:199-204.
37. Lukehart, S. A., C. Gordones, B. J. Molini, P. Sonnett, S. Hopkins, F. Mulcahy, J. Engelman, S. J. Mitchell, A. M. Rompalo, C. M. Marra, and J. D. Klausner. 2004. Macrolide resistance in Treponema pallidum in the United States and Ireland. N. Engl. J. Med. 351:154-158.
38. Lukehart, S. A., E. W. Hook III, S. A. Baker-Zander, A. C. Collier, C. W. Critchlow, and H. H. Handsfield. 1988. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann. Intern. Med. 109:855-862.
39. Marra, C. M. 2009. Update on neurosyphilis. Curr. Infect. Dis. Rep. 11:127-134.
40. Marra, C. M., P. Boutin, J. C. McArthur, S. Hurwitz, G. Simpson, P. A. J. Haslett, C. van der Horst, T. Nevin, E. W. Hook III, and the AIDS Clinical Trials Group (ACTG). 2000. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin. Infect. Dis. 30:540-544.
41. Marra, C. M., A. P. Colina, C. Godornes, L. C. Tantalo, M. Puray, A. Centurion-Lara, and S. A. Lukehart. 2006. Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum. J. Infect. Dis. 194:1771-1773.
42. Martin, I. E., W. Gu, Y. Yang, and R. S. Tsang. 2009. Macrolide resistance and molecular types of Treponema pallidum causing primary syphilis in Shanghai, China. Clin. Infect. Dis. 49:515-521.
43. Martin, I. E., R. S. Tang, K. Sutherland, P. Tilley, R. Read, B. Anderson, C. Roy, and A. E. Singh. 2009. Molecular characterization of syphilis in patients in Canada: azithromycin resistance and detection of Treponema pallidum DNA in whole-blood samples versus ulcerative swabs. J. Clin. Microbiol. 47:1668-1673.
44. Matejkova, P., M. Flasarova, H. Zakoucka, M. Borek, S. Kremenova, P. Arenberger, V. Woznicova, G. M. Weinstock, and D. Smajs. 2009. Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in 23S rRNA gene of Treponema pallidum subsp. pallidum. J. Med. Microbiol. 58:832-836.
45. Matejkova, P., M. Strouhal, D. Smajs, S. J. Norris, T. Palzkill, J. F. Petrosino, E. Sodergren, J. E. Norton, J. Singh, T. A. Richmond, M. N. Molla, T. J. Albert, and G. M. Weinstock. 2008. Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays. BMC Microbiol. 8:76.
46. Meljanac, N., E. Dippel, and C. C. Zouboulis. 1999. Superimposed primary chancre in a patient with Adamantiades-Behcet's disease. Sex. Transm. Infect. 75:124-125.
47. Mitchell, S. J., J. Engelman, C. K. Kent, S. A. Lukehart, C. Gordones, and J. D. Klausner. 2006. Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. Clin. Infect. Dis. 42:337-345.
48. Mohr, J. A., W. Griffths, R. Jackson, H. Saadah, P. Bird, and J. Riddle. 1976. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA 236:2208-2209.
49. Moorthy, T. T., C. T. Lee, K. B. Kim, and T. Tan. 1987. Ceftriaxone for treatment of primary syphilis in men: a preliminary study. Sex. Transm. Dis. 14:116-118.
50. Morshed, M. G., and H. D. Jones. 2006. Treponema pallidum macrolide resistance in BC. CMAJ 174:349.
51. Myint, M., H. Bashiri, R. D. Harrington, and C. M. Marra. 2004. Relapse of secondary syphilis after benzathine penicillin G. Molecular analysis. Sex. Transm. Dis. 31:196-199.
52. Onoda, Y. 1979. Therapeutic effect of oral doxycycline on syphilis. Br. J. Vener. Dis. 55:110-115.
53. Pandori, M. W., C. Gordones, L. Castro, J. Engelman, M. Siedner, S. Lukehart, and J. Klausner. 2007. Detection of azithromycin resistance in Treponema pallidum by real-time PCR. Antimicrob. Agents Chemother. 51:3425-3430.
54. Paster, B. J., and F. E. Dewhirst. 2006. The phylogenetic diversity of the genus Treponema, p. 9-18. In J. D. Radolf and S. A. Lukehart (ed.), Pathogenic Treponema molecular and cellular biology. Caister Academic Press, Norfolk, England.
55. Philipson, A., L. D. Sabath, and D. Charles. 1973. Transplacental passage of erythromycin and clindamycin. N. Engl. J. Med. 288:1219-1221.
56. Prapasarakul, N., K. Ochi, and Y. Adachi. 2003. In vitro susceptibility and a new point mutation associated with tylosin-resistance in Japanese canine intestinal spirochetes. J. Vet. Sci. 65:1275-1280.
57. Pringle, M., C. Fellstrom, and K. E. Johansson. 2007. Decreased susceptibility to doxycycline associated with a 16S rRNA gene mutation in Brachyspira hyodysenteriae. Vet. Microbiol. 123:245-248.
58. Rekart, M. L., D. M. Patrick, B. Chakraborty, J. J. L. Maginley, H. D. Jones, C. D. Bajdik, B. Pourbohloul, and R. C. Brunham. 2003. Target mass treatment for syphilis with oral azithromycin. Lancet 361:313-314.
59. Riedner, G., M. Rusizoka, J. Todd, L. Maboko, M. Hoelscher, D. Mmbando, E. Samky, E. Lyamuya, D. Mabey, H. Grosskurth, and R. Hayes. 2005. Single-dose erythromycin versus penicillin G benzathine for the treatment of early syphilis. N. Engl. J. Med. 353:1236-1244.
60. Roberts, M. C. 2005. Update on acquired tetracycline resistance genes. FEMS Microbiol. Lett. 245:195-203.
61. Roberts, M. C. 2008. Update on macrolide-lincosamide- streptogramin, ketolides, and oxazolidinone resistance genes. FEMS Microbiol. Lett. 282:147-159.
62. Rolfs, R. T., M. R. Joesoef, E. F. Hendershot, A. M. Rompalo, M. H. Augenbraun, M. Chiu, G. Bolan, S. C. Johnson, P. French, E. Steen, J. D. Radolf, and S. Larsen. 1997. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N. Engl. J. Med. 337:307-314.
63. Rompalo, A. M. 2001. Can syphilis be eradicated from the world? Curr. Opin. Infect. Dis. 14:41-44.
64. Ross, J. I., E. A. Eady, J. H. Cove, and W. J. Cunliffe. 1998. 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob. Agents Chemother. 42:1702-1705.
65. Ross, J. I., E. A. Eady, J. H. Cove, C. E. Jones, A. H. Ratyal, Y. W. Miller, S. Vyakrnam, and W. J. Cunliffe. 1997. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob. Agents Chemother. 41:1162-1165.
66. Schmid, G. P., B. P. Stoner, S. Hawkes, and N. Broutet. 2007. The need and plan for global elimination of congenital syphilis. Sex. Transm. Dis. 34(Suppl.):S5-S10.
67. Simms, I., K. A. Fenton, M. Ashton, K. M. Turner, E. E. Crawley-Boevey, R. Gorton, D. R. Thomas, A. Lynch, A. Winter, M. J. Fisher, L. Lighton, H. C. Maguire, and M. Solomou. 2005. The re-emergence of syphilis in the United Kingdom: the new epidemic phases. Sex. Transm. Dis. 32:220-226.
68. Smith, N. H., D. M. Musher, D. B. Huang, P. S. Rodriguez, M. E. Dowell, W. Ace, and A. C. White, Jr. 2004. Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int. J. STD AIDS 15:328-332.
69. South, M. A., D. H. Short, and J. M. Knox. 1964. Failure of erythromycin estolate therapy in in utero syphilis. JAMA 190:70-71.
70. Stamm, L. V. 2001. Treponema pallidum, p. 1795-1808. In M. Sussman (ed.), Molecular medical microbiology, 1st ed. Academic Press, London, United Kingdom.
71. Stamm, L. V., and H. L. Bergen. 2000. A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. Antimicrob. Agents Chemother. 44:806-807.
72. Stamm, L. V., H. L. Bergen, and K. A. Shangraw. 2001. Natural rifampin resistance in Treponema spp. correlates with presence of N531 in RpoB rif cluster I. Antimicrob. Agents Chemother. 45:2973-2974.
73. Stamm, L. V., and E. A. Parrish. 1990. In-vitro activity of azithromycin and CP-63,956 against Treponema pallidum. J. Antimicrob. Chemother. 25(Suppl. A):S11-S14.
74. Stamm, L. V., J. T. Stapleton, and P. J. Bassford, Jr. 1988. In vitro assay to demonstrate high-level erythromycin resistance in a clinical isolate of Treponema pallidum. Antimicrob. Agents Chemother. 32:164-169.
75. Stapleton, J. T., L. V. Stamm, and P. J. Bassford, Jr. 1985. Potential for development of antibiotic resistance in pathogenic treponemes. Rev. Infect. Dis. 7(Suppl. 2):S314-S317.
76. Stoner, B. P. 2007. Current controversies in the management of adult syphilis. Clin. Infect. Dis. 44:S130-146.
77. Tichonova, L., K. Borisenko, H. Ward, A. Meheus, A. Gromyko, and A. Renton. 1997. Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for control. Lancet 350:210-213.
78. Tramont, E. C. 1976. Persistence of Treponema pallidum following penicillin G therapy. Report of two cases. JAMA 236:2206-2207.
79. Verdon, M. S., H. H. Handsfield, and R. B. Johnson. 1994. Pilot study of azithromycin for treatment of primary and secondary syphilis. Clin. Infect. Dis. 19:486-488.
80. Vester, B., and S. Douthwaite. 2001. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45:1-12.
81. Wang, G., and D. E. Taylor. 1998. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob. Agents Chemother. 42:1952-1958.
82. Weigel, L. M., J. D. Radolf, and M. V. Norgard. 1994. The 47-kDa major lipoprotein immunogen of Treponema pallidum is a penicillin-binding protein with carboxypeptidase activity. Proc. Natl. Acad. Sci. U. S. A. 91:11611-11615.
83. Wong, T., A. E. Singh, and P. De. 2008. Primary syphilis: serological treatment response to doxycycline/tetracycline versus benzathine penicillin. Am. J. Med. 121:903-908.
84. Woznicova, V., D. Smajs, D. Wechsler, P. Matejkova, and M. Flasarova. 2007. Detection of Treponema pallidum subsp. pallidum from skin lesions, serum, and cerebrospinal fluid in an infant with congenital syphilis after clindamycin treatment of the mother during pregnancy. J. Clin. Microbiol. 45:659-661.
85. Wu, J. Y., J. J. Kim, R. Reddy, W. M. Wang, D. Y. Graham, and D. H. Kwon. 2005. Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob. Agents Chemother. 49:578-583.
86. Zapun, A., C. Contreras-Martel, and T. Vernet. 2008. Penicillin-binding proteins and beta-lactam resistance. FEMS Microbiol. Rev. 32:361-385.
87. Zhou, P., Z. Gu, J. Xu, X. Wang, and K. Liao. 2005. A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy. Sex. Transm. Dis. 32:495-498.